Katerina Chavatza

Athens, ESYE31, Greece

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Development and validation of EULAR quality indicators for lupus nephritis: adherence trends and impact on clinical outcomes.

Development and validation of EULAR quality indicators for lupus nephritis: adherence trends and impact on clinical outcomes.

Journal: Annals of the rheumatic diseases
Published: March 11, 2026

No benefit of adding glucocorticoids to maintenance treatment in reducing the risk of major relapses in ANCA-associated vasculitis: real life data from a longitudinal cohort study.

No benefit of adding glucocorticoids to maintenance treatment in reducing the risk of major relapses in ANCA-associated vasculitis: real life data from a longitudinal cohort study.

Journal: RMD open
Published: March 10, 2026

Temporal trends in lupus pregnancy over four decades in a referral centre: pregnancy planning and hydroxychloroquine use are associated with improved outcomes.

Temporal trends in lupus pregnancy over four decades in a referral centre: pregnancy planning and hydroxychloroquine use are associated with improved outcomes.

Journal: Rheumatology advances in practice
Published: July 31, 2025

Persistent-relapsing SARS-CoV-2 infection following rituximab treatment for autoimmune rheumatic diseases: diagnosis and outcomes.

Persistent-relapsing SARS-CoV-2 infection following rituximab treatment for autoimmune rheumatic diseases: diagnosis and outcomes.

Journal: RMD open
Published: April 03, 2025

Enhanced B cell and complement cascade gene signatures in patients with neuropsychiatric systemic lupus erythematosus.

Enhanced B cell and complement cascade gene signatures in patients with neuropsychiatric systemic lupus erythematosus.

Journal: Annals of the rheumatic diseases
Published: January 09, 2025

Transcriptome analysis to decipher the molecular underpinnings of response to treatment in systemic lupus erythematosus.

Transcriptome analysis to decipher the molecular underpinnings of response to treatment in systemic lupus erythematosus.

Journal: RMD open
Published: September 26, 2024

Relapses and serious adverse events during rituximab maintenance therapy in ANCA-associated vasculitis: a multicentre retrospective study.

Relapses and serious adverse events during rituximab maintenance therapy in ANCA-associated vasculitis: a multicentre retrospective study.

Journal: Rheumatology (Oxford, England)
Published: June 02, 2024

Breakthrough COVID-19 Infections after Booster SARS-CoV-2 Vaccination in a Greek Cohort of People Living with HIV during the Delta and Omicron Waves.

Breakthrough COVID-19 Infections after Booster SARS-CoV-2 Vaccination in a Greek Cohort of People Living with HIV during the Delta and Omicron Waves.

Journal: Biomedicines
Published: May 21, 2024

Can we predict kidney involvement in patients with systemic lupus erythematosus? A retrospective cohort study with independent validation.

Can we predict kidney involvement in patients with systemic lupus erythematosus? A retrospective cohort study with independent validation.

Journal: Rheumatology (Oxford, England)
Published: February 05, 2024

Residual disease activity and treatment intensification in systemic lupus erythematosus: A cross-sectional study to quantify the need for new therapies.

Residual disease activity and treatment intensification in systemic lupus erythematosus: A cross-sectional study to quantify the need for new therapies.

Journal: Lupus
Published: September 28, 2022

Quality indicators for systemic lupus erythematosus based on the 2019 EULAR recommendations: development and initial validation in a cohort of 220 patients.

Quality indicators for systemic lupus erythematosus based on the 2019 EULAR recommendations: development and initial validation in a cohort of 220 patients.

Journal: Annals of the rheumatic diseases
Published: March 26, 2021

Transition to severe phenotype in systemic lupus erythematosus initially presenting with non-severe disease: implications for the management of early disease.

Transition to severe phenotype in systemic lupus erythematosus initially presenting with non-severe disease: implications for the management of early disease.

Journal: Lupus science & medicine
Published: March 12, 2020
Showing 1-12 of 13

Last Updated: 09/26/2026